Sign in

CIK 0001107421 · Non-accelerated filer<br>Smaller reporting company

Alaunos Therapeutics, Inc.

Sign in to watch
Ticker
TCRT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
841475642
Phone
(346) 355-4099
Business address
501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
Former names
ZIOPHARM ONCOLOGY INC, EASYWEB INC
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Grant or award EVP, Chief Financial Officer acquired 80,500 shares (grant or award)
  4. 4 Grant or award President acquired 80,500 shares (grant or award)
  5. 4 Grant or award SVP, Treasurer & CAO acquired 18,000 shares (grant or award)
  6. 4 Grant or award General Counsel and Secretary acquired 59,100 shares (grant or award)
  7. 4 Grant or award EVP, GM Cell Therapy acquired 53,700 shares (grant or award)
  8. 4 Grant or award Chief Executive Officer acquired 171,700 shares (grant or award)
  9. 4 Grant or award EVP, GM Gene Therapy acquired 53,700 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 4 Shares withheld for taxes Director gave up 20,054 shares (to pay taxes)
  12. 4 Open-market sale President sold 22,394 shares at $4.55 ($101,893)
  13. 4 Open-market sale SVP, Treasurer & CAO sold 21,570 shares at $4.55 ($98,144)
  14. 4 Grant or award Director acquired 31,780 shares (grant or award)
  15. 4 Open-market sale General Counsel and Secretary sold 16,853 shares at $4.55 ($76,681)
  16. 4 Shares withheld for taxes Director gave up 40,107 shares (to pay taxes)
  17. 4 Open-market sale EVP, GM Cell Therapy sold 24,890 shares at $4.55 ($113,250)
  18. 4 Open-market sale EVP, GM Gene Therapy sold 27,923 shares at $4.55 ($127,050)
  19. 4 Grant or award Director acquired 31,780 shares (grant or award)
  20. 4 Derivatives Options or other derivatives

Page 7 of 24 · 465 filings